4893 items matching your search terms.

Circumferential location predicts the risk of high-grade dysplasia and early adenocarcinoma in short-segment Barrett's esophagus

Kariyawasam, VC Bourke, MJ Hourigan, LF Lim, G Moss, A Williams, SJ Fanning, SB Chung, AM, Byth, K
GASTROINTESTINAL ENDOSCOPY, 2012     DOI:10.1016/j.gie.2011.12.025

The role of statin therapy in patients with lower vascular risk [editorial]

Keech, AC Fulcher, JR Simes, J
MEDICAL JOURNAL OF AUSTRALIA, 2012     DOI:10.5694/mja12.10925.

The role of statin therapy in patients with lower vascular risk

Keech, A. C. Fulcher, J. R. Simes, J.
MEDICAL JOURNAL OF AUSTRALIA, 2012     DOI:10.5694/mja12.10925

The impact of illness on retirement finances

Kelly, SJ Percival, R Schofield, DJ Shrestha, RN Callander, EJ Passey, ME
ECONOMIC RECORD, 2012     DOI:10.1111/j.1475-4932.2012.00845.x

Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: a systematic review of contemporary randomized trials

Kiely, BE Alam, M Blinman, P Tattersal, MHN Stockler, MR
LUNG CANCER, 2012     DOI:10.1016/j.lungcan.2012.04.017

The median informs the message: the accuracy of individualized scenarios for survival time based on oncologists' estimates

Kiely, BE Martin, AJ Tattersall, MHN Nowak, AK Goldstein, D Wilcken, NR Wyld, DK Abdi, EA Glasgow, A Beale, PJ Jefford, M Glare, PA Stockler, MR

Usefulness of medical oncologists’ estimates of survival time in people with advanced cancer

Kiely, BE Martin, AJ Tattersall, MHN Nowak, AK Goldstein, D Wilcken, N Wyld, D Beale, PJ Jefford, M Glasgow, AL Abdi, EA Glare, PA Stockler, MR

Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience

Kiely, BE McCaughan, G Christodoulou, S Beale, PJ Grimison, P Trotman, J Tattersall, MHN Stockler, MR

Meta-analysis: adjuvant tamoxifen reduces recurrence and death at 15 years in ER-positive early breast cancer (review)

Kiely, B Stockler, M

Multilevel latent variable models for global health-related quality of life assessment

Kifley, A Heller, GZ Beath, KJ Bulger, D Ma, J Gebski, V
STATISTICS IN MEDICINE, 2012     DOI:10.1002/sim.4455

Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer

King, MT Viney, R Smith, DP Hossain, I Street, D Savage, E Fowler, S Berry, MP Stockler, M Cozzi, P Stricker, P Ward, J Armstrong, BK
BRITISH JOURNAL OF CANCER, 2012     DOI:10.1038/bjc.2011.552

Workforce shortages in medical oncology: a looming threat to quality cancer care

Koczwara, B Barton, MB Walpole, ET Grimison, P Blinman, PL Crossing, S Francis, K

Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: results from a randomised controlled trial

Kondalsamy-Chennakesavan, S Janda, M Gebski, V Baker, J Brand, A Hogg, R Jobling, TW Land, R Manolitsas, T Nascimento, M Neesham, D Nicklin, JL Oehler, MK Otton, G Perrin, L Salfinger, S Hammond, I Leung, Y Sykes, P Ngan, H Garrett, A Laney, M Ng, TY Tam, K Chan, K Wrede, DH Pather, S Simcock, B Farrell, R Robertson, G Walker, G McCartney, A Obermair, A
EUROPEAN JOURNAL OF CANCER, 2012     DOI:10.1016/j.ejca.2012.03.013

Does current Australian clinical trial activity for national health priority areas reflect their disease burden?

Lam, JCY Lord, SJ Hunter, KE Ooi, WYT Askie, LM

A randomized double-blind trial of carboplatin plus paclitaxel with daily oral cediranib, an inhibitor of vascular endothelial growth factor receptors, or placebo in patients with previously untreated advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29

Laurie, SA Solomon, BJ Seymour, L Ellis, PM Goss, BD Shepherd, FA Boyer, MJ Arnold, AM Clingan, P Laberge, F Fenton, D Hirsh, V Zukin, M Stockler, MR Lee, CW Chen, EX Montenegro, A Ding, K Bradbury, PA NCIC Clinical Trials Group,